Finance
European Health Chief Says Review of New Weight-Loss Pill Will Conclude by Summer
Published by Global Banking & Finance Review®
Posted on April 22, 2026
1 min readLast updated: April 22, 2026
Add as preferred source on Google
Quick Summary
EU Medicines Agency chief Emer Cooke said at Reuters Pharma Europe in Barcelona that the review of the first oral GLP‑1 weight‑loss pill is expected to wrap up by summer, with both Novo Nordisk’s Wegovy pill and Eli Lilly’s orforglipron/Fourndayo under consideration.
European Medicines Agency to Conclude Review of New Weight-Loss Pill by Summer
EU Regulatory Review of Weight-Loss Pills Nears Completion
BARCELONA, April 22 (Reuters) - The head of the European Medicines Agency, Emer Cooke, said on Wednesday that the EU regulatory review of the first of a new generation of weight-loss pills would be concluded this summer.
Statements from the European Medicines Agency
Cooke, speaking at the Reuters Pharma Europe 2026 event in Barcelona, said the review would be finished "very soon". Denmark's Novo Nordisk and U.S. rival Eli Lilly have recently launched pills in the United States.
Industry Developments
Reporting and Editing Credits
(Reporting by Maggie Fick; Writing by Ludwig Burger; Editing by Louise Heavens)
Key Takeaways
- •Emer Cooke said the EU regulatory review of a new oral weight‑loss pill will conclude “very soon,” likely before summer when regulatory decision‑making slows (reddit.com).
- •Novo Nordisk’s oral Wegovy pill was approved in the U.S. in December 2025 and plans are underway to expand into Europe; the company is investing in European production (axios.com).
- •Eli Lilly’s weight‑loss pill orforglipron (Foundayo) received expedited FDA approval in April 2026 and is already shipping in the U.S., while its EU review appears to be nearing completion (apnews.com)
References
Frequently Asked Questions about European health chief says review of new weight-loss pill will conclude by summer
1When will the European review of the new weight-loss pill be completed?
The European Medicines Agency expects to finish reviewing the new weight-loss pill by summer.
2Which companies have launched the new weight-loss pills?
Novo Nordisk from Denmark and Eli Lilly from the U.S. have launched new weight-loss pills.
3Who announced the timeline for the regulatory review?
Emer Cooke, head of the European Medicines Agency, announced the review timeline.
4Where was the review update announced?
The update on the review was announced at the Reuters Pharma Europe 2026 event in Barcelona.
